| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 58
| Issue : 4 | Page : 268-273 |
|
|
Newer anti-vascular endothelial growth factor agents
Priya Rasipuram Chandrasekaran
Department of Ophthalmology, Lotus Eye Hospital, Salem, Tamil Nadu, India
Correspondence Address:
Dr. Priya Rasipuram Chandrasekaran
Eye Hospital, Salem, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/tjosr.tjosr_98_20
|
|
|
Ocular angiogenesis is a major cause of ocular morbidity worldwide. Vascular endothelial growth factor (VEGF) is a critical regulator of angiogenesis and vascular permeability with diverse roles both during the development and adulthood. This is believed to be the most powerful mediator of angiogenesis leading to ischemia-induced neovascularization in the retinal and choroidal diseases. Anti-VEGF has revolutionized the treatment of such angiogenic and exudative diseases of the retina and choroid. This article gives a brief view of the newer anti-VEGF agents and their role in retinal diseases.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
